Dashboard
Manage Tickers

CDNACareDx, Inc.

Nasdaq caredx.com


$ 29.27 $ -0.86 (-2.86 %)    

Wednesday, 18-Sep-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 29.26
$ 29.78
$ 29.24 x 200
-- x --
$ 28.95 - $ 31.11
$ 4.80 - $ 34.84
630,252
na
1.54B
$ 1.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

caredx-names-keith-kennedy-as-coo-and-jessica-meng-as-chief-commercial-officer
CareDx Names Keith Kennedy As COO And Jess...
09/12/2024 11:08:40

CareDx will be sharing its long-term growth strategy during an Investor Day in October 2024.

wells-fargo-initiates-coverage-on-caredx-with-underweight-rating-announces-price-target-of-28
Wells Fargo Initiates Coverage On CareDx w...
08/27/2024 21:54:27

Wells Fargo analyst Brandon Couillard initiates coverage on CareDx (NASDAQ:CDNA) with a Underweight rating and announces Pri...

what-4-analyst-ratings-have-to-say-about-caredx
What 4 Analyst Ratings Have To Say About C...
08/19/2024 14:00:15

btig-upgrades-caredx-to-buy-announces-40-price-target
BTIG Upgrades CareDx to Buy, Announces $40...
08/19/2024 13:22:26

BTIG analyst Sung Ji Nam upgrades CareDx (NASDAQ:CDNA) from Neutral to Buy and announces $40 price target.

caredx-announces-cms-retires-draft-policy-restricting-coverage-restoring-longstanding-coverage-for-allosure-allomap-and-heartcare-through-surveillance-testing-for-allograft-rejection
CareDx Announces CMS Retires Draft Policy ...
08/16/2024 18:11:24

goldman-sachs-maintains-buy-on-caredx-raises-price-target-to-26
Goldman Sachs Maintains Buy on CareDx, Rai...
08/01/2024 17:27:25

Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $16 to $26.

craig-hallum-maintains-buy-on-caredx-raises-price-target-to-32
Craig-Hallum Maintains Buy on CareDx, Rais...
08/01/2024 16:59:21

Craig-Hallum analyst Connor Chamberlain maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $22 to $32.

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
08/01/2024 13:48:38

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

why-carvana-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why Carvana Shares Are Trading Higher By 1...
08/01/2024 12:32:25

caredx-q2-2024-adj-eps-025-beats-014-estimate-sales-92274m-beat-67861m-estimate
CareDx Q2 2024 Adj. EPS $0.25 Beats $(0.14...
07/31/2024 20:37:50

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.14) by 278...

where-caredx-stands-with-analysts
Where CareDx Stands With Analysts
07/17/2024 16:00:38

goldman-sachs-maintains-buy-on-caredx-raises-price-target-to-16
Goldman Sachs Maintains Buy on CareDx, Rai...
07/17/2024 16:00:00

Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $14 to $16.

decoding-6-analyst-evaluations-for-caredx
Decoding 6 Analyst Evaluations For CareDx
05/31/2024 18:01:19

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
05/31/2024 17:52:10

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

caredx-to-present-new-data-at-the-2024-american-transplant-congress-being-held-june-1-5-in-philadelphia
CareDx To Present New Data At The 2024 Ame...
05/30/2024 11:28:22

CareDx solutions are featured in 36 oral presentations and posters, and a symposium. The findings highlight innovative approach...

Core News & Articles
CareDx Informed Natera And The Court, Sinc...
05/29/2024 12:31:22

CareDx Reiterates Position that it Does Not Infringe Natera's ‘544 Patent Injunction Motion has No Impact on CareDx's ...

top-3-health-care-stocks-that-may-crash-in-may
Top 3 Health Care Stocks That May Crash In...
05/24/2024 11:53:28

craig-hallum-maintains-buy-on-caredx-raises-price-target-to-22
Craig-Hallum Maintains Buy on CareDx, Rais...
05/17/2024 12:09:14

Craig-Hallum analyst Connor Chamberlain maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $15 to $22.

caredx-presents-findings-from-the-shore-study-heartcare-outperforms-dd-cfdna-alone-in-identifying-rejection-and-patients-experienced-fewer-biopsies
CareDx Presents Findings from The SHORE St...
05/16/2024 20:24:00

HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular RejectionCardiologists Performed the Fewes...

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
05/15/2024 15:32:55

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION